SE7703263L - Forfarande for framstellning av nya acetohydroxaminsyror - Google Patents

Forfarande for framstellning av nya acetohydroxaminsyror

Info

Publication number: SE7703263L
Authority: SE; Sweden
Prior art keywords: alkyl; cycloalkyl; optionally substituted; conh; phenyl
Prior art date: 1976-03-23

Application number

SE7703263A

Other languages

English (en)

Other versions

SE432420B (sv

Inventor

L Lafon

Original Assignee

Lafon Labor

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-03-23

Filing date

1977-03-22

Publication date

1977-09-24

1977-03-22 Application filed by Lafon Labor filed Critical Lafon Labor

1977-09-24 Publication of SE7703263L publication Critical patent/SE7703263L/sv

1984-04-02 Publication of SE432420B publication Critical patent/SE432420B/sv

Links

RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical class CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 title abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
-1 hydantoinyl Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000003107 substituted aryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/72—Acyl halides containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/56—Radicals substituted by sulfur atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

SE7703263A 1976-03-23 1977-03-22 Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror SE432420B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB11710/76A GB1574822A (en)	1976-03-23	1976-03-23	Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
GB629877		1977-02-15

Publications (2)

Publication Number	Publication Date
SE7703263L true SE7703263L (sv)	1977-09-24
SE432420B SE432420B (sv)	1984-04-02

Family

ID=26240593

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
SE7703263A SE432420B (sv)	1976-03-23	1977-03-22	Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror
SE8302172A SE458605B (sv)	1976-03-23	1983-04-19	Foerfarande foer framstaellning av acetohydroxamsyror
SE8302173A SE456992B (sv)	1976-03-23	1983-04-19	Foerfarande foer framstaellning av 2-(1-fenyl-bensimidazolyl)-acetohydroxamsyra
SE8302171A SE452155B (sv)	1976-03-23	1983-04-19	Analogiforfarande for framstellning av terapeutiskt verksamma arylsulfinylacetohydroxamsyraderivat

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
SE8302172A SE458605B (sv)	1976-03-23	1983-04-19	Foerfarande foer framstaellning av acetohydroxamsyror
SE8302173A SE456992B (sv)	1976-03-23	1983-04-19	Foerfarande foer framstaellning av 2-(1-fenyl-bensimidazolyl)-acetohydroxamsyra
SE8302171A SE452155B (sv)	1976-03-23	1983-04-19	Analogiforfarande for framstellning av terapeutiskt verksamma arylsulfinylacetohydroxamsyraderivat

Country Status (25)

Country	Link
US (7)	US4122186A (sv)
JP (1)	JPS52144601A (sv)
AT (5)	AT356078B (sv)
AU (1)	AU516473B2 (sv)
BE (1)	BE852738A (sv)
CA (2)	CA1120928A (sv)
CH (1)	CH620894A5 (sv)
CS (1)	CS200511B2 (sv)
DD (1)	DD129645A5 (sv)
DE (1)	DE2711451A1 (sv)
DK (1)	DK171197B1 (sv)
ES (1)	ES457105A1 (sv)
FI (1)	FI62821C (sv)
FR (4)	FR2345430A1 (sv)
GB (1)	GB1574822A (sv)
IE (1)	IE44721B1 (sv)
IL (1)	IL51705A (sv)
LU (1)	LU76989A1 (sv)
NL (1)	NL188801C (sv)
NO (4)	NO144420C (sv)
NZ (1)	NZ183616A (sv)
PH (1)	PH16271A (sv)
PT (1)	PT66300B (sv)
SE (4)	SE432420B (sv)
SU (1)	SU689617A3 (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1584462A (en) *	1977-03-31	1981-02-11	Lafon Labor	N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
US4405357A (en)	1980-06-02	1983-09-20	Fmc Corporation	Herbicidal 3-isoxazolidinones and hydroxamic acids
FR2502617B1 (sv) *	1981-03-25	1984-04-27	Lafon Labor
FR2528041A1 (fr) *	1982-06-04	1983-12-09	Lafon Labor	Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
JPS59222454A (ja) *	1983-05-31	1984-12-14	Ajinomoto Co Inc	アミノ酸の製造方法
US4604407A (en) *	1985-04-04	1986-08-05	E. R. Squibb & Sons, Inc.	Hydroxamates
FR2584666B1 (fr) *	1985-07-10	1989-06-16	Champion Spark Plug Europ	Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2585699B1 (fr) *	1985-07-31	1988-03-11	Lafon Labor	Derive d'acide acetohydroxamique, procede de preparation et utilisation en therapeutique
US5036157A (en) *	1986-03-11	1991-07-30	Burroughs Wellcome Co.	Aryl derivatives
FR2601673B2 (fr) *	1986-07-21	1989-06-02	Lafon Labor	Derives de l'acetamide et medicaments qui en contiennent
US4983567A (en) *	1987-03-16	1991-01-08	Biomeasure, Inc.	Immunomodulators and methods of making same
ES2011588A6 (es) *	1989-05-29	1990-01-16	Vinas Lab	Procedimiento para la preparacion de un nuevo derivado fenilacetico.
JPH0359402U (sv) *	1989-10-13	1991-06-12
US5283248A (en) *	1989-11-21	1994-02-01	Hoffmann-La Roche Inc.	Amino substituted pyrimido[1,6-2]benzimidazoles
CA2028530A1 (en) *	1989-11-21	1991-05-22	Christian Hubschwerlen	Substituted pyrimidobenzimidazole derivatives
US5378701A (en) *	1991-12-27	1995-01-03	Kyowa Hakko Kogyo	Tricyclic compounds
US6060477A (en) *	1995-06-07	2000-05-09	Cell Pathways, Inc.	Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
AU748998B2 (en) *	1997-02-27	2002-06-13	Wyeth Holdings Corporation	N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6172057B1 (en)	1997-02-27	2001-01-09	American Cyanamid Company	N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6187924B1 (en) *	1997-11-12	2001-02-13	Darwin Discovery, Ltd.	Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
PE20001566A1 (es)	1999-03-26	2001-02-05	Ucb Sa	Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6686502B1 (en)	1999-03-26	2004-02-03	Ucb S.A.	Compounds and methods for treatment of asthma, allergy and inflammatory disorders
GB9911071D0 (en) *	1999-05-12	1999-07-14	Darwin Discovery Ltd	Hydroxamic and carboxylic acid derivatives
DE60216972T2 (de) *	2001-12-04	2007-10-18	De Novo Pharmaceuticals Ltd., Histon	Bakterielle enzyminhibitoren
DE10320453A1 (de) *	2003-05-08	2004-11-25	Morphochem AG Aktiengesellschaft für kombinatorische Chemie	Neue Bioisostere von Actinonin
US7842835B2 (en) *	2003-07-07	2010-11-30	Georgetown University	Histone deacetylase inhibitors and methods of use thereof
EP1644323B1 (en) *	2003-07-07	2015-03-18	Georgetown University	Histone deacetylase inhibitors and methods of use thereof
US7378426B2 (en) *	2004-03-01	2008-05-27	Bristol-Myers Squibb Company	Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) *	2004-03-01	2008-08-26	Bristol-Myers Squibb Company	Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US20090264384A1 (en) *	2004-11-01	2009-10-22	Nuada, Inc.	Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
WO2007134169A2 (en) *	2006-05-10	2007-11-22	Nuada, Llc	Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
WO2007113644A2 (en) *	2006-04-05	2007-10-11	Orchid Research Laboratories Limited	New hdac inhibitors
SG172685A1 (en)	2006-06-28	2011-07-28	Amgen Inc	Glycine transporter-1 inhibitors
KR20090064400A (ko) *	2006-09-28	2009-06-18	머크 앤드 캄파니 인코포레이티드	Ｈｄａｃ 억제제 및 킬레이트화 가능한 금속 화합물 및 금속-ｈｄａｃ 억제제 킬레이트 착물의 약제학적 조성물
CA2667826C (en) *	2006-10-28	2013-10-08	Methylgene Inc.	Inhibitors of histone deacetylase
WO2008094592A1 (en) *	2007-02-01	2008-08-07	Panthera Biopharna, Llc	Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
FR2957492B1 (fr)	2010-03-18	2013-08-16	Rhodia Operations	Nouvelles utilisations de composes de type esteramide
CN101982459A (zh) *	2010-10-21	2011-03-02	山东华尔康生物技术有限公司	乙酰氧肟酸的制备工艺
GB201509663D0 (en) *	2015-06-03	2015-07-15	Johnson Matthey Plc	Benzo(h)quinoline ligands and complexes thereof
US11993575B1 (en)	2023-12-29	2024-05-28	King Faisal University	Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound
US11970462B1 (en)	2024-01-03	2024-04-30	King Faisal University	Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound
US12172968B1 (en)	2024-01-25	2024-12-24	King Faisal University	4-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2862020A (en) *		1958-11-25		Derivatives of a-amino-p-hydroxy
US2279560A (en) *	1940-05-08	1942-04-14	Du Pont	Viscous hydrocarbon oil
US2397508A (en) *	1943-05-29	1946-04-02	Standard Oil Co	Hydroxamic acids
GB894119A (en) *	1959-11-02	1962-04-18	Ici Ltd	Pivalic acid derivative
US3275643A (en) *	1963-07-19	1966-09-27	Irwin I Lubowe	Allantoin-pantothenate compounds
US3634509A (en) *	1966-06-08	1972-01-11	Shell Oil Co	2 6-dinitroanilinoacetamides
NL6715600A (sv) *	1966-12-02	1968-06-04
US3927092A (en) *	1968-06-24	1975-12-16	Merck & Co Inc	Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1805548A1 (de) *	1968-10-26	1970-10-08	Agfa Gevaert Ag	Benzimidazol-Derivate und ihre photographische Verwendung
FR2036953A1 (en) *	1969-04-23	1970-12-31	Pluripharm	Diphenylhydantoin derivs
US4092430A (en) *	1970-09-09	1978-05-30	Ciba-Geigy Corporation	Antiphlogistic phenylacetohydroxamic acid compositions
US3728380A (en) *	1971-05-17	1973-04-17	Morton Norwich Products Inc	P-chlorobenzamidoacetohydroxamic acid
US3839580A (en) *	1972-08-14	1974-10-01	Morton Norwich Products Inc	2-p-(nitrobenzamido)acetohydroxamic for treating urinary tract infections
SE7411007L (sv) *	1973-10-10	1975-04-11	Ciba Geigy Ag
JPS51102636A (en) *	1974-04-03	1976-09-10	Fuji Photo Film Co Ltd	Karaashashingazo no keiseihoho
FR2285867A1 (fr) *	1974-09-30	1976-04-23	Lafon Labor	Derives du diphenylsulfoxyde
CH593954A5 (sv) *	1975-07-21	1977-12-30	Ciba Geigy Ag
US4029812A (en) *	1976-02-18	1977-06-14	The Dow Chemical Company	Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides

1976
- 1976-03-23 GB GB11710/76A patent/GB1574822A/en not_active Expired
1977
- 1977-03-08 PH PH19538A patent/PH16271A/en unknown
- 1977-03-09 FR FR7706997A patent/FR2345430A1/fr active Granted
- 1977-03-14 PT PT66300A patent/PT66300B/pt unknown
- 1977-03-15 IE IE561/77A patent/IE44721B1/en not_active IP Right Cessation
- 1977-03-16 NZ NZ183616A patent/NZ183616A/xx unknown
- 1977-03-16 DE DE19772711451 patent/DE2711451A1/de active Granted
- 1977-03-17 US US05/778,543 patent/US4122186A/en not_active Expired - Lifetime
- 1977-03-17 AU AU23344/77A patent/AU516473B2/en not_active Expired
- 1977-03-18 FI FI770859A patent/FI62821C/fi not_active IP Right Cessation
- 1977-03-21 AT AT193077A patent/AT356078B/de not_active IP Right Cessation
- 1977-03-21 CH CH347977A patent/CH620894A5/fr not_active IP Right Cessation
- 1977-03-21 LU LU76989A patent/LU76989A1/xx unknown
- 1977-03-21 IL IL51705A patent/IL51705A/xx unknown
- 1977-03-22 BE BE175998A patent/BE852738A/xx not_active IP Right Cessation
- 1977-03-22 NO NO771006A patent/NO144420C/no unknown
- 1977-03-22 CA CA000274470A patent/CA1120928A/en not_active Expired
- 1977-03-22 SE SE7703263A patent/SE432420B/sv not_active IP Right Cessation
- 1977-03-22 DK DK126677A patent/DK171197B1/da not_active IP Right Cessation
- 1977-03-22 CS CS771904A patent/CS200511B2/cs unknown
- 1977-03-22 ES ES457105A patent/ES457105A1/es not_active Expired
- 1977-03-23 SU SU772465454A patent/SU689617A3/ru active
- 1977-03-23 NL NLAANVRAGE7703168,A patent/NL188801C/xx not_active IP Right Cessation
- 1977-03-23 DD DD7700198023A patent/DD129645A5/xx unknown
- 1977-03-23 JP JP3201177A patent/JPS52144601A/ja active Granted
1978
- 1978-08-04 US US05/930,927 patent/US4151300A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,926 patent/US4152458A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,924 patent/US4209523A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,928 patent/US4209524A/en not_active Expired - Lifetime
- 1978-08-04 US US05/930,925 patent/US4183951A/en not_active Expired - Lifetime
- 1978-11-24 AT AT839978A patent/AT358556B/de not_active IP Right Cessation
- 1978-11-24 AT AT839878A patent/AT361932B/de not_active IP Right Cessation
- 1978-11-24 AT AT0840078A patent/AT362793B/de not_active IP Right Cessation
1979
- 1979-08-24 US US06/069,254 patent/US4225617A/en not_active Expired - Lifetime
1980
- 1980-03-13 FR FR8005644A patent/FR2453148A1/fr active Granted
- 1980-03-13 FR FR8005645A patent/FR2453133A1/fr active Granted
- 1980-03-13 FR FR8005646A patent/FR2453158A1/fr active Granted
- 1980-10-09 AT AT0501480A patent/AT374191B/de not_active IP Right Cessation
- 1980-11-06 NO NO803336A patent/NO146431C/no unknown
- 1980-11-06 NO NO803338A patent/NO145881C/no unknown
- 1980-11-06 NO NO803337A patent/NO152972C/no unknown
1981
- 1981-04-22 CA CA375,997A patent/CA1130301A/en not_active Expired
1983
- 1983-04-19 SE SE8302172A patent/SE458605B/sv not_active IP Right Cessation
- 1983-04-19 SE SE8302173A patent/SE456992B/sv not_active IP Right Cessation
- 1983-04-19 SE SE8302171A patent/SE452155B/sv not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE2711451C2 (sv)	1990-05-10
ATA839878A (de)	1980-09-15
FR2453148A1 (fr)	1980-10-31
FR2453158B1 (sv)	1982-08-06
CH620894A5 (sv)	1980-12-31
FI62821C (fi)	1983-03-10
IE44721B1 (en)	1982-03-10
NO771006L (no)	1977-09-26
LU76989A1 (sv)	1977-07-18
NO152972C (no)	1985-12-27
US4151300A (en)	1979-04-24
NO145881B (no)	1982-03-08
US4152458A (en)	1979-05-01
DK171197B1 (da)	1996-07-22
SE8302173D0 (sv)	1983-04-19
SU689617A3 (ru)	1979-09-30
SE458605B (sv)	1989-04-17
NZ183616A (en)	1979-03-28
SE8302173L (sv)	1983-04-19
FI62821B (fi)	1982-11-30
AT374191B (de)	1984-03-26
SE432420B (sv)	1984-04-02
FR2345430B1 (sv)	1982-07-23
CA1120928A (en)	1982-03-30
IL51705A0 (en)	1977-05-31
ATA839978A (de)	1980-02-15
IE44721L (en)	1977-09-23
US4122186A (en)	1978-10-24
NL188801C (nl)	1992-10-01
FI770859A7 (sv)	1977-09-24
SE456992B (sv)	1988-11-21
BE852738A (fr)	1977-09-22
CS200511B2 (en)	1980-09-15
NO803337L (no)	1977-09-26
AT362793B (de)	1981-06-10
NL7703168A (nl)	1977-09-27
NO803338L (no)	1977-09-26
AU516473B2 (en)	1981-06-04
PT66300B (pt)	1978-08-10
CA1130301A (en)	1982-08-24
ATA193077A (de)	1979-09-15
SE452155B (sv)	1987-11-16
AT356078B (de)	1980-04-10
NO144420B (no)	1981-05-18
JPS52144601A (en)	1977-12-02
AU2334477A (en)	1978-09-21
PH16271A (en)	1983-08-25
SE8302172L (sv)	1983-04-19
ATA501480A (de)	1983-08-15
IL51705A (en)	1982-09-30
JPS628424B2 (sv)	1987-02-23
US4183951A (en)	1980-01-15
PT66300A (fr)	1977-04-01
US4209524A (en)	1980-06-24
NO144420C (no)	1981-08-26
FR2453158A1 (fr)	1980-10-31
DE2711451A1 (de)	1977-10-06
FR2453133B1 (sv)	1984-04-06
NO145881C (no)	1982-06-16
DK126677A (da)	1977-09-24
SE8302172D0 (sv)	1983-04-19
US4225617A (en)	1980-09-30
FR2453133A1 (fr)	1980-10-31
US4209523A (en)	1980-06-24
AT358556B (de)	1980-09-25
FR2453148B1 (sv)	1983-12-02
ES457105A1 (es)	1978-10-16
NO152972B (no)	1985-09-16
GB1574822A (en)	1980-09-10
AT361932B (de)	1981-04-10
NO803336L (no)	1977-09-26
NO146431C (no)	1982-09-29
NO146431B (no)	1982-06-21
SE8302171L (sv)	1983-04-19
FR2345430A1 (fr)	1977-10-21
DD129645A5 (de)	1978-02-01
SE8302171D0 (sv)	1983-04-19
ATA840078A (de)	1980-11-15

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 7703263-9

Format of ref document f/p: F

1997-06-09

NUG

Patent has lapsed